Analyst Research

Report Title Price
Provider: GlobalData
Provider: ValuEngine, Inc.
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

H Lundbeck A/S Announces Changes in Commercial Structure and Potential Positions' Reduction

Thursday, 20 Jun 2013 07:30am EDT 

H Lundbeck A/S announced that the Company plans to further optimize its commercial structure in order to be able to successfully launch new medicines. As part of its plan, Lundbeck will divide its commercial operations into six regions: Europe, USA, Canada, Asia, Latin America and Middle East & Global Distribution. This reflects the global diversification of the company and ensures full focus on growth markets. Furthermore Lundbeck plans to simplify the commercial structure in Europe by organizing its more than 30 affiliates in 10 strong business units. This will enhance Lundbeck’s ability to launch new medicines. If the restructure is carried through it may regrettably lead to a reduction of 50-55 positions in Europe. Lundbeck has informed the Company's European and Danish Works Council about the restructuring plans. 

Company Quote

0.7 +0.52%
22 May 2015